The FDA issued an approvable letter for Dacogen (decitabine) injection, a treatment for myelodysplastic syndromes (MDS) that is partnered between MGI Pharma Inc. and SuperGen Inc., but a request for more material put a slight dent in shares of both companies. (BioWorld Today) Read More
